ghk cu peptide ellie md EllieMD | Longevity GHK-CU – Research Peptide |
Description
Available from: Specific concomitant medical conditions may raise risk The injections are typically not given when certain complicating medical conditions are present, such as infections, tumors, or bleeding disorders
Immune Reactivity: The FDA has previously flagged concerns that compounded peptides like BPC 157 carry risks of triggering unexpected immune or allergic reactions
Completely 100% agree, Reptar
This finding indicates that p53 TAD PEP effectively competes with p53 TAD for FOXO4 FHD binding
